| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $275.5M | -15.6% |
| Cost of Revenue | $267.9M | -5.9% |
| Gross Profit | $7.6M | -81.7% |
| R&D Expense | $23.2M | -17.5% |
| SG&A Expense | $217.8M | +28.3% |
| Operating Income | -$333.6M | -113.7% |
| Pre-tax Income | $219.1M | +236.7% |
| Income Tax | $0 | +100.0% |
| Net Income | $219.0M | +236.7% |
| EPS (Basic) | $1.15 | +147.3% |
| EPS (Diluted) | -$1.83 | +24.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $203.9M | +54.6% |
| Accounts Receivable | $26.1M | -3.0% |
| Inventory | $84.0M | -25.9% |
| Current Assets | $341.5M | +19.2% |
| Total Assets | $614.7M | -9.3% |
| Current Liabilities | $74.9M | +21.9% |
| Long-term Debt | $415.7M | -63.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$144.9M | -46.7% |
| Capital Expenditures | $12.3M | +11.7% |
| Investing Cash Flow | -$10.3M | -64.5% |
| Financing Cash Flow | $223.4M | +388.0% |
| Free Cash Flow | -$157.2M | -43.2% |
| -$997K |
| +99.8% |